These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 38997755)

  • 1. The interplay of inflammation and remyelination: rethinking MS treatment with a focus on oligodendrocyte progenitor cells.
    Zveik O; Rechtman A; Ganz T; Vaknin-Dembinsky A
    Mol Neurodegener; 2024 Jul; 19(1):53. PubMed ID: 38997755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligodendrocyte progenitor cell recruitment and remyelination in multiple sclerosis: the more, the merrier?
    Tepavčević V; Lubetzki C
    Brain; 2022 Dec; 145(12):4178-4192. PubMed ID: 36093726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid of progressive multiple sclerosis patients reduces differentiation and immune functions of oligodendrocyte progenitor cells.
    Zveik O; Fainstein N; Rechtman A; Haham N; Ganz T; Lavon I; Brill L; Vaknin-Dembinsky A
    Glia; 2022 Jun; 70(6):1191-1209. PubMed ID: 35266197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs in oligodendrocyte development and remyelination.
    Ngo C; Kothary R
    J Neurochem; 2022 Aug; 162(4):310-321. PubMed ID: 35536759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of Tuberous Sclerosis Complex1 in Adult Oligodendrocyte Progenitor Cells Enhances Axon Remyelination and Increases Myelin Thickness after a Focal Demyelination.
    McLane LE; Bourne JN; Evangelou AV; Khandker L; Macklin WB; Wood TL
    J Neurosci; 2017 Aug; 37(31):7534-7546. PubMed ID: 28694334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligodendrocyte precursor cells as a therapeutic target for demyelinating diseases.
    Skaper SD
    Prog Brain Res; 2019; 245():119-144. PubMed ID: 30961866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total astragalosides promote oligodendrocyte precursor cell differentiation and enhance remyelination in cuprizone-induced mice through suppression of Wnt/β-catenin signaling pathway.
    Yuan J; Xu N; Tao Y; Han X; Yang L; Liang J; Jin H; Zhang X; Wu H; Shi H; Huang F; Wu X
    J Ethnopharmacol; 2022 Nov; 298():115622. PubMed ID: 35964820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinases shape the oligodendrocyte (niche) during development and upon demyelination.
    Gorter RP; Baron W
    Neurosci Lett; 2020 Jun; 729():134980. PubMed ID: 32315713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunology of oligodendrocyte precursor cells in vivo and in vitro.
    Antel JP; Lin YH; Cui QL; Pernin F; Kennedy TE; Ludwin SK; Healy LM
    J Neuroimmunol; 2019 Jun; 331():28-35. PubMed ID: 29566973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNFR2 Signaling Regulates the Immunomodulatory Function of Oligodendrocyte Precursor Cells.
    Desu HL; Illiano P; Choi JS; Ascona MC; Gao H; Lee JK; Brambilla R
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin Restores CNS Remyelination Capacity by Rejuvenating Aged Stem Cells.
    Neumann B; Baror R; Zhao C; Segel M; Dietmann S; Rawji KS; Foerster S; McClain CR; Chalut K; van Wijngaarden P; Franklin RJM
    Cell Stem Cell; 2019 Oct; 25(4):473-485.e8. PubMed ID: 31585093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The fate and function of oligodendrocyte progenitor cells after traumatic spinal cord injury.
    Duncan GJ; Manesh SB; Hilton BJ; Assinck P; Plemel JR; Tetzlaff W
    Glia; 2020 Feb; 68(2):227-245. PubMed ID: 31433109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors that retard remyelination in multiple sclerosis with a focus on TIP30: a novel therapeutic target.
    Nakahara J; Aiso S; Suzuki N
    Expert Opin Ther Targets; 2009 Dec; 13(12):1375-86. PubMed ID: 19839715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering biomaterial microenvironments to promote myelination in the central nervous system.
    Unal DB; Caliari SR; Lampe KJ
    Brain Res Bull; 2019 Oct; 152():159-174. PubMed ID: 31306690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory milieu at the multiple sclerosis lesion site and the challenges for remyelination.
    Galloway DA; Gowing E; Setayeshgar S; Kothary R
    Glia; 2020 May; 68(5):859-877. PubMed ID: 31441132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelin regulatory factor drives remyelination in multiple sclerosis.
    Duncan GJ; Plemel JR; Assinck P; Manesh SB; Muir FGW; Hirata R; Berson M; Liu J; Wegner M; Emery B; Moore GRW; Tetzlaff W
    Acta Neuropathol; 2017 Sep; 134(3):403-422. PubMed ID: 28631093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schwann cell remyelination of the central nervous system: why does it happen and what are the benefits?
    Chen CZ; Neumann B; Förster S; Franklin RJM
    Open Biol; 2021 Jan; 11(1):200352. PubMed ID: 33497588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ginsenoside Rg1 promotes remyelination and functional recovery in demyelinating disease by enhancing oligodendrocyte precursor cells-mediated myelin repair.
    Liu L; Du X; Yang Q; Li M; Ran Q; Liu Q; Yang L; Sun L; Guo Y; Li Y; Chen Y; Zhu X; Li Q
    Phytomedicine; 2022 Nov; 106():154309. PubMed ID: 35994846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phloretin enhances remyelination by stimulating oligodendrocyte precursor cell differentiation.
    Dierckx T; Vanherle S; Haidar M; Grajchen E; Mingneau F; Gervois P; Wolfs E; Bylemans D; Voet A; Nguyen T; Hamad I; Kleinewietfeld M; Bogie JFJ; Hendriks JJA
    Proc Natl Acad Sci U S A; 2022 Nov; 119(46):e2120393119. PubMed ID: 36343243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oligodendrocyte precursor cells present antigen and are cytotoxic targets in inflammatory demyelination.
    Kirby L; Jin J; Cardona JG; Smith MD; Martin KA; Wang J; Strasburger H; Herbst L; Alexis M; Karnell J; Davidson T; Dutta R; Goverman J; Bergles D; Calabresi PA
    Nat Commun; 2019 Aug; 10(1):3887. PubMed ID: 31467299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.